Fisher & Paykel Healthcare (FSPKF) Expected to Announce Earnings on Monday

Fisher & Paykel Healthcare (OTCMKTS:FSPKFGet Free Report) is expected to be posting its results before the market opens on Monday, May 25th. Analysts expect Fisher & Paykel Healthcare to post earnings of $0.2457 per share and revenue of $698.6510 million for the quarter.

Fisher & Paykel Healthcare Price Performance

OTCMKTS FSPKF opened at $20.55 on Monday. The company has a 50 day simple moving average of $22.80 and a 200-day simple moving average of $22.14. Fisher & Paykel Healthcare has a 52-week low of $16.35 and a 52-week high of $25.69.

Wall Street Analysts Forecast Growth

Separately, Royal Bank Of Canada raised shares of Fisher & Paykel Healthcare to a “sector perform” rating in a research report on Tuesday, February 24th. One research analyst has rated the stock with a Hold rating, According to MarketBeat, Fisher & Paykel Healthcare presently has a consensus rating of “Hold”.

Check Out Our Latest Research Report on Fisher & Paykel Healthcare

About Fisher & Paykel Healthcare

(Get Free Report)

Fisher & Paykel Healthcare Corporation Limited is a New Zealand-based medical device company that specializes in the design, manufacture and marketing of products and systems for respiratory care and the treatment of obstructive sleep apnea. Headquartered in Auckland, the company focuses on delivering therapeutic solutions that enhance patient outcomes across a range of acute and chronic respiratory conditions.

The company’s product portfolio includes humidification systems used in mechanical ventilation, high-flow nasal cannula therapy devices for adult and neonatal care, continuous positive airway pressure (CPAP) machines and interfaces for sleep apnea treatment, as well as medical devices for non-invasive ventilation.

Featured Stories

Receive News & Ratings for Fisher & Paykel Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fisher & Paykel Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.